Status:
UNKNOWN
Cefepime and Unictam on Preventing Post-Cesarean Surgical Site Infections
Lead Sponsor:
Beni-Suef University
Conditions:
Cesarean Section; Infection
Eligibility:
FEMALE
18-40 years
Phase:
PHASE3
Brief Summary
the aim of this study is to evaluate the efficacy of employing cefepime (CFM) versus ampicillin/sulbactam (AMS) in lowering the rate of post-cesarean surgical site infections.
Detailed Description
A prospective randomized clinical study conducted in the department of obstetrics and gynecology of Beni-Suef University Hospital . A total of 213 women were assessed for eligibility, 13 of which were...
Eligibility Criteria
Inclusion
- Pregnant women within age group more than18 years.
- Pregnant women with elective cesarean delivery.
- Previous and primary cesarean delivery.
Exclusion
- Severe hepatic disease women Emergent cesarean deliveries. Women with medical disorders as pre-gestational diabetes, anemia, hypertension, or preeclampsia.
- Women who had a skin infection adjacent to the operative site.
Key Trial Info
Start Date :
January 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 20 2023
Estimated Enrollment :
213 Patients enrolled
Trial Details
Trial ID
NCT06048692
Start Date
January 1 2023
End Date
September 20 2023
Last Update
September 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beni-suef university Hospital
Banī Suwayf, Beni Suweif Governorate, Egypt, 62521